Why do some people with the same genetic disease experience vastly different symptoms, and why do some treatments work wonders for one patient but fail for another? The answer might lie hidden within the seemingly repetitive stretches of our DNA, in structures called Short Tandem Repeats (STRs). Groundbreaking research from The Hospital for Sick Children (SickKids) is shedding light on how subtle variations within these repeats can dramatically influence disease severity and treatment response, potentially revolutionizing how we understand and treat genetic disorders.
These findings, published in Genome Biology, delve into the intricate world of STRs, repetitive DNA sequences that make up a significant portion – around seven percent – of our entire genome. We already knew that expansions of these repeats are linked to diseases like Huntington's disease, fragile X syndrome, autism spectrum disorder, schizophrenia, cancer, and cardiomyopathies. But here's where it gets controversial... the SickKids team discovered that it's not just the length of these repeats that matters. The sequence within those repeats plays a vital role, too.
“These changes in STR composition aren’t rare; they’re a normal part of human genetic diversity. This is a new dimension of genetic variation that’s been hiding in plain sight,” explains Dr. Ryan Yuen, a senior scientist at SickKids and the senior author of the study. Imagine a brick wall (the STR) built with slightly different shaped bricks (the sequence motifs). While the wall’s overall length (repeat length) might be similar, the subtle differences in brick shape can significantly impact the wall’s strength and stability (gene regulation and disease manifestation).
The researchers analyzed the STR sequence composition of over 3,000 individuals from two different datasets. To do this, they employed a sophisticated algorithm developed at SickKids, capable of detecting both the length and the motif composition of the repeats. And this is the part most people miss... This allowed them to uncover the relationships between these STR variations and gene expression across 49 different human tissue types. It’s like having a super-powered magnifying glass to examine the minute details of our genetic code.
The analysis revealed fascinating patterns. Variable STRs, those with diverse sequence motifs, tend to cluster near regions of DNA called Alu elements, and are more prone to expansion. Even more intriguing, these variable STRs are frequently found near splice junctions of genes crucial for brain and neuronal functions. The SickKids team specifically identified an enrichment of these variable STRs near genes linked to “neuron,” “axon,” and “growth” functions, in brain regions like the hippocampus, hypothalamus, nucleus accumbens, and putamen – areas vital for motor control, learning, reward, language, and cognition. This strongly suggests that variations in these STRs can directly impact brain development and function.
Furthermore, the study highlighted ethnic differences in STR variation, with a higher frequency of alternative motifs observed in people of African descent. The team also identified previously unknown motifs in regions associated with monogenic repeat disorders. This raises a critical question: Could differences in STR motifs contribute to the observed disparities in disease prevalence and severity across different populations?
These findings have profound implications for clinical care. Knowing that STR sequence composition, rather than just length, can influence gene expression and disease pathways could revolutionize diagnostic interpretation, risk assessment, and prognosis. For example, two patients with Huntington's disease might have similar repeat lengths, but vastly different symptoms due to variations in the underlying STR sequence. Understanding these differences could help tailor treatment strategies for each individual.
“We saw clear patterns, like these diverse repeats appearing in genes related to neurodevelopment and brain function,” says Dr. Alexandra (Sasha) Mitina, a research fellow at SickKids and the first author of the study. “Genes affected by these variations are linked to critical biological processes and may help explain individual differences in health and disease.”
There are also significant implications for drug development. Instead of solely focusing on repeat length, future therapies could target pathways influenced by the specific motif composition. This could lead to more effective and personalized treatments for diseases driven by tandem repeats. And as long-read sequencing technology becomes more accessible, it will become even easier to analyze both the size and sequence composition of STRs, paving the way for more precise diagnoses and targeted therapies.
“Our approach lets us see both size and sequence composition. We’re still only scratching the surface, but these regions may hold the answers to some of the unknowns in our genome and contain potential targets for future disease studies,” Yuen concludes. But here's the real kicker: this research challenges the long-held assumption that repeat length is the primary driver of STR-related diseases. By uncovering the importance of sequence motifs, the SickKids team has opened a new chapter in our understanding of the human genome and its impact on health.
What do you think about these findings? Could this explain why some people respond better to certain medications than others? Do you believe that personalized medicine, based on STR sequence composition, is the future of healthcare? Share your thoughts in the comments below!
